BMAL1 and myocardial ischemia: Given the apparent circadian rhythmicity of cardiovascular disease, studies targeting small molecule modulators of BMAL1 may have an important role in the treatment of myocardial ischemia, with a view to bringing about more personalized and effective therapeutic regimens for patients with cardiovascular disease.